Home / Candesartan and Diuretics / Austria
AT ATC C09DA06 · updated 2 Nov 2026
Candesartan and Diuretics shortage in Austria
Is there a Candesartan and Diuretics shortage in Austria?
Yes. As of 2 Nov 2026, 3 Candesartan and Diuretics products are reported short in Austria, the first since 6 Dec 2025. The company estimate for the return is 5 Dec 2028 (latest 8 Apr 2029). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Czechia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Blopress Plus 32 mg/25 mg - Tabletten, 28 Stück | Cheplapharm Arzneimittel GmbH | 6 Dec 2025 | 5 Dec 2028 | Commercial decision or withdrawal Vorübergehende Einstellung des Inverkehrbringens |
| AT | Blopress Plus 32 mg/12,5 mg - Tabletten, 28 Stück | Cheplapharm Arzneimittel GmbH | 9 Apr 2026 | 8 Apr 2029 | Commercial decision or withdrawal Vorübergehende Einstellung des Inverkehrbringens |
| AT | Candesartan/HCT 1A Pharma 32 mg/12,5 mg - Tabletten, 30 Stück | 1 A Pharma GmbH | 27 Oct 2026 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).